Kordonouri O, Jörres A, Müller C, Enders I, Gahl G M, Weber B
Department of Pediatrics, Universitätsklinikum Rudolf Virchow, Berlin-Charlottenburg, Germany.
Scand J Clin Lab Invest. 1992 Dec;52(8):781-90. doi: 10.3109/00365519209088381.
In an effort to establish a reliable programme for the clinical monitoring of renal involvement in patients with type-I diabetes mellitus, we quantified the urinary excretion of immunoglobulin G (IgG), transferrin (Tf), albumin (Alb), alpha 1-microglobulin (alpha 1MG), N-acetyl-beta-D-glucosaminidase (NAG), and total protein in 130 dipstick negative children and young adults with type-I diabetes. Eighty-five sex- and age-matched healthy persons served as a control group for the definition of the upper reference limits (95th centiles; micrograms min-1 1.73 m2): transferrin 1.4; albumin 16.6; total protein 27.1; NAG: 2.0 mU min-1 1.73 m2. Sex-related differences were detected for IgG (men: 3.8; women: 1.7) and alpha 1 MG (men: 6.0; women: 4.0 micrograms min-1 1.73 m2). The urinary excretion of IgG, Tf, alpha 1MG, NAG, and total protein was significantly higher in subjects with diabetes when compared to healthy controls (p < 0.01). Furthermore, 20 patients (15%) showed an elevated excretion of tubular markers (alpha 1MG and NAG), and 3 patients (2%) of at least two glomerular markers (Alb and/or Tf and/or IgG). Additionally, 18 individuals (14%) presented a mixed excretion pattern of both tubular and glomerular markers. These data suggest that the quantitation of both glomerular and tubular proteinuria provides a sensitive and cost-effective instrument for the non-invasive screening for renal involvement in patients with diabetes mellitus.
为建立一个可靠的临床监测方案,用于监测Ⅰ型糖尿病患者的肾脏受累情况,我们对130名尿试纸检测为阴性的Ⅰ型糖尿病儿童和青年的免疫球蛋白G(IgG)、转铁蛋白(Tf)、白蛋白(Alb)、α1-微球蛋白(α1MG)、N-乙酰-β-D-氨基葡萄糖苷酶(NAG)以及总蛋白的尿排泄量进行了定量分析。85名年龄和性别匹配的健康人作为对照组,用于确定参考上限(第95百分位数;微克每分钟每1.73平方米):转铁蛋白1.4;白蛋白16.6;总蛋白27.1;NAG:2.0毫单位每分钟每1.73平方米。检测到IgG(男性:3.8;女性:1.7)和α1MG(男性:6.0;女性:4.0微克每分钟每1.73平方米)存在性别差异。与健康对照组相比,糖尿病患者的IgG、Tf、α1MG、NAG和总蛋白的尿排泄量显著更高(p < 0.01)。此外,20名患者(15%)显示肾小管标志物(α1MG和NAG)排泄升高,3名患者(2%)至少有两种肾小球标志物(Alb和/或Tf和/或IgG)排泄升高。另外,18名个体(14%)呈现肾小管和肾小球标志物混合排泄模式。这些数据表明,肾小球和肾小管蛋白尿的定量分析为糖尿病患者肾脏受累的无创筛查提供了一种敏感且经济有效的手段。